Nursing Review Issue 5 September-October 2021 | Page 2

For formula-fed infants For healthcare professional use only

S-26 Alula Gold Newborn Providing nutritional support for key areas of paediatric development and function

Growth and Development
• Contains a lower-protein quantity of 1.28g / 100mL .
• Feeding infants a lower protein # formula during infancy may encourage appropriate weight gain , closer to breast-fed infants during early childhood development up to 6 years . 1 , 2
• Enriched with sn-2 palmitate . Sn-2 enriched infant formula is associated with increased bone mineral content . 3
Digestion
• Sn-2 palmitate enriched formula is associated with improved absorption of calcium and fat and may result in softer stools . 3-7
• Easy to digest whey dominant , whole ( intact ) protein . 8 , 9
• Whey : casein ratio 65:35
Immunity
• Contains Nucleotides and zinc . Naturally found in breast milk , they may help support immunity . 10-15
Brain Development
• The DHA content ( min . 0.32 %) of S-26 Alula Gold Newborn closely aligns with the average DHA content of mature breast milk * and expert recommendations . 16-18
# Versus higher-protein formula * Mean concentration 0.32 %+/ - 0.22 % † At 4 months of age
IMPORTANT STATEMENT : Breastfeeding is best for babies . It has benefits for the infant , such as reducing infection risk , and for the mother . It is important to have a healthy balanced diet in preparation for , and during breastfeeding . Infant formula is designed to replace breast milk when an infant is not breastfed . Breastfeeding can be negatively affected by introducing partial bottle-feeding , and reversing a decision not to breastfeed is difficult . Infant formula must be prepared and used as directed . Unnecessary or improper use of infant formula , such as not properly boiling water or sterilising feeding equipment , may make your baby ill . Social and financial implications , including preparation time and the cost of formula , should be considered when selecting a method of infant feeding .
References 1 . Koletzko , B ., et al ., 2009 . AJCN , 89 : 1836-1845 . 2 . Weber et al . 2014 . Am . J . Clin . Nutr ., 99 : 1041-1051 . 3 . Béghin L et al ., 2019 , Clin . Nutr . Jun ; 38 ( 3 ): 1023- 1030 . 4 . Kennedy et al . 1999 . Am . J . Clin . Nutr ., 70 : 920-927 . 5 . Yao , M ., et al ., 2014 . JPGN , 59 : 440-448 . 6 . Bar-Yoseph et al . 2013 . PLEFA , 89 : 139-143 . 7 . Bronsky J , et al . J Pediatr Gastroenterol Nutr . 2019 May ; 68 ( 5 ): 742-760 . 8 . Lönnerdal , B . 2003 . AJCN , 77:1537S-1543S . 9 . Martin , C ., et al ., 2016 , Nutrients , 8 ( 279 ), pp . 1-11 . 10 . Yu , V ., 2002 , J . Paediatr . Child Health : 38 , pp . 543-549 11 . Hess , J . & Greenberg , N ., 2012 ,: Am . Soc . Par . Ent . Nutr ., 27 ( 2 ), pp . 281-294 12 . Singhal , A ., et al ., 2008 . AJCN , 87 : 1785-1792 13 . Ackland , M . & Michalczyk , A ., 2016 , Archives of Biochemistry and Biophysics , 611 , pp . 51-57 14 . Aumeistere L ., et al ., 2018 , , Nutrients , 10 ( 1438 ), 1-9 . 15 . Carver , J ., 1999 , Acta Paediatr Suppl : 430 , pp . 83-8.16 . Brenna , J . T ., et al . 2007 . AJCN , 85 : 1457-1464.17 . Koletzko , B ., et al 2008 ., J . Perinat . Med ., 36 , pp . 5-14 . 18 . European Food Safety Authority ( EFSA ), 2014 , EFSA Journal , 12 ( 7 ): 3760 , pp . 1-106 .
Or visit : www . alula . com . au Phone : 1800 552 229 www . meandmychild . com . au
S-26 is a registered trade mark . Used Under licence . Distributed by Sanulac Nutritionals Australia Pty Ltd . Level 1 , 42-44 Chandos Street , St Leonards , NSW 2065 . AN-05377-03082021